HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Monika Fritzer-Szekeres Selected Research

digalloylresveratrol

10/2013Digalloylresveratrol, a novel resveratrol analog inhibits the growth of human pancreatic cancer cells.
12/2011Combination effects of digalloylresveratrol with arabinofuranosylcytosine and difluorodeoxycytidine in human leukemia and pancreatic cancer cells.
2/2009Digalloylresveratrol, a new phenolic acid derivative induces apoptosis and cell cycle arrest in human HT-29 colon cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Monika Fritzer-Szekeres Research Topics

Disease

26Neoplasms (Cancer)
11/2017 - 08/2002
14Leukemia
10/2017 - 08/2002
4Coronary Artery Disease (Coronary Atherosclerosis)
06/2020 - 01/2014
4Inflammation (Inflammations)
01/2019 - 01/2011
4Pancreatic Neoplasms (Pancreatic Cancer)
10/2013 - 02/2008
3Diabetes Mellitus
06/2020 - 11/2017
3Breast Neoplasms (Breast Cancer)
09/2012 - 12/2006
3Colonic Neoplasms (Colon Cancer)
02/2009 - 08/2004
2Heart Failure
06/2020 - 02/2014
2Cardiovascular Diseases (Cardiovascular Disease)
01/2019 - 08/2018
2Atherosclerosis
11/2017 - 01/2014
2Insulin Resistance
11/2017 - 06/2014
2Type 2 Diabetes Mellitus (MODY)
06/2014 - 01/2014
2Lymphoma (Lymphomas)
03/2009 - 07/2005
1Chronic Renal Insufficiency
06/2020
1Hypertension (High Blood Pressure)
06/2020
1Ovarian Neoplasms (Ovarian Cancer)
01/2020
1Portal Hypertension
01/2020
1Hepatitis C
01/2020
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2019
1Cardiomyopathies (Cardiomyopathy)
01/2019
1Myocardial Infarction
01/2019
1Stroke (Strokes)
01/2019
1Ischemia
01/2019
1Heart Valve Diseases (Valvular Heart Disease)
11/2017
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2017
1Pathologic Processes
01/2017
1Pathologic Neovascularization
10/2016
1Morbid Obesity
06/2014
1Melanoma (Melanoma, Malignant)
01/2011

Drug/Important Bio-Agent (IBA)

14Cytarabine (Cytosar-U)FDA LinkGeneric
10/2017 - 08/2002
13Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
10/2017 - 08/2002
10ResveratrolIBA
10/2013 - 03/2005
6DNA (Deoxyribonucleic Acid)IBA
01/2015 - 03/2005
5EnzymesIBA
10/2013 - 08/2002
4Pharmaceutical PreparationsIBA
10/2017 - 09/2003
4Floxuridine (FUdR)FDA LinkGeneric
07/2005 - 09/2003
3Estrogens (Estrogen)FDA Link
01/2020 - 12/2010
3digalloylresveratrolIBA
10/2013 - 02/2009
3Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2011 - 01/2007
3AvemarIBA
03/2009 - 02/2005
3StilbenesIBA
06/2008 - 10/2006
2C-Reactive ProteinIBA
11/2017 - 01/2014
2Antineoplastic Agents (Antineoplastics)IBA
10/2017 - 01/2004
2EndostatinsIBA
10/2016 - 02/2014
2Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
10/2016 - 02/2014
2Proteins (Proteins, Gene)FDA Link
01/2015 - 10/2009
2triphosphoric acid (triphosphate)IBA
01/2015 - 12/2010
2PolyphenolsIBA
01/2015 - 10/2009
2LipidsIBA
06/2014 - 01/2014
2Hormones (Hormone)IBA
06/2014 - 09/2007
23,3',4,5'-tetrahydroxystilbeneIBA
12/2010 - 10/2008
2Fluorouracil (Carac)FDA LinkGeneric
02/2009 - 08/2004
2Gallic AcidIBA
02/2009 - 01/2007
2CytidineIBA
02/2009 - 03/2005
2Deuterium Oxide (Heavy Water)IBA
02/2008 - 09/2005
2Phosphates (Orthophosphate)IBA
01/2005 - 08/2004
2Carmustine (FIVB)FDA Link
10/2004 - 08/2004
23,4-dihydroxybenzohydroxamic acidIBA
10/2004 - 08/2004
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2020
1Lipoprotein(a)IBA
06/2020
1PlatinumIBA
01/2020
1InterferonsIBA
01/2020
1Fatty Acid Binding Protein 3IBA
01/2019
1Urokinase Plasminogen Activator ReceptorsIBA
01/2019
1Troponin IIBA
01/2019
1omega-Chloroacetophenone (Mace)IBA
01/2019
1Biomarkers (Surrogate Marker)IBA
01/2019
1TroponinIBA
01/2019
1Protein Isoforms (Isoforms)IBA
01/2019
1Fatty Acid-Binding ProteinsIBA
01/2019
1Advanced Glycation End ProductsIBA
08/2018
1cathepsin SIBA
11/2017
1ThiosemicarbazonesIBA
10/2017
1HydrazonesIBA
10/2017
1OsteopontinIBA
10/2016
1Rosmarinic AcidIBA
01/2015
1Free RadicalsIBA
01/2015
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
01/2015
1Ellagic AcidIBA
01/2015
1Angiopoietin-Like Protein 8IBA
06/2014
1Uric Acid (Urate)IBA
01/2014
1HDL CholesterolIBA
01/2014
1NitrogenIBA
01/2014
1Glucose (Dextrose)FDA LinkGeneric
01/2014
1Heavy MetalsIBA
01/2014
1Environmental Pollutants (Pollutants, Environmental)IBA
01/2014
1Triglycerides (Triacylglycerol)IBA
01/2014
1CreatinineIBA
01/2014
1Urea (Carbamide)FDA LinkGeneric
01/2014
1Cytochrome P-450 CYP1A1 (CYP1A1)IBA
09/2012
1Estrogen ReceptorsIBA
09/2012
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2011
1N-hydroxy-N'-aminoguanidineIBA
01/2011
1Mitogen-Activated Protein KinasesIBA
12/2010

Therapy/Procedure

9Drug Therapy (Chemotherapy)
01/2020 - 08/2002
3Therapeutics
01/2020 - 10/2004
2Combination Drug Therapy (Combination Chemotherapy)
03/2005 - 10/2004
1Cytoreduction Surgical Procedures
01/2020
1Endurance Training
01/2017